The general subtyping of breast cancer is based on the presence of transmembrane and intracellular receptors, namely, estrogen (ER), progesterone (PR) and the human epidermal growth factor receptor 2 (HER2, also referred to as ERBB2) [2, 3]. This evidence concerns the gene ERBB2 and breast carcinoma.